Magforce Logo
NanoTherm M01
NanoTherm M02
NanoTherm M03
Thermosensitive Drug Carrier
Phase

The MagForce magnetofluid with the name "M01" consists of iron oxide particles which are colloidally dispersed in water. The particle core mainly consists of magnetite. Images taken with a transmission electron microscope (TEM) show an average particle size (without coating) of approx. 10 - 15 nanometers. This small size is a prerequisite for the finely dispersed distribution of the particles within the liquid.

Furthermore, the iron oxide cores are surrounded by a protective covering which is not visible on TEM images and which makes sure the particles are stable enough that they do not agglomerate or sedimentize. In the "M01" magnetofluid, the protective covering is made of aminosilanes. These deposit themselves on the particle surface, forming a closed protective coating around the nanoparticles. This type of stabilization makes it possible to realize high iron concentrations in the magnetofluid, which, in turn, is key for subsequent treatment.

MagForce therapy works only with nanoparticles

Only nanoparticles absorb the high-energy radiation of the magnetic field.

Due to their enormous specific surface, only nanoparticles are able to produce a large number of binding sites between cancer cells and target molecules.

Only nanoparticles can penetrate deeply into the tumor tissue.

Only nanoparticles with a correspondingly adapted chemical coating

  • are not identified as foreign bodies by the immune system until a late stage.
  • can be absorbed by cancer cells in sufficiently high quantities.
  • are evenly distributed in a fluid with low viscosity.
MagForce nanoparticles